Major GI events among elderly chronic users of COX-2s and non-selective NSAIDs, with/without aspirin

被引:0
|
作者
Wang, J
Mullins, CD
Naradzay, JF
Howard, K
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Pfizer, New York, NY USA
关键词
D O I
10.1016/S1098-3015(10)64440-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A44 / A44
页数:1
相关论文
共 50 条
  • [21] Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*
    Anna I. Gunnarsdóttir
    Moira Kinnear
    Pharmacy World and Science, 2005, 27 : 316 - 320
  • [22] COX-2 NSAIDs plus GI protective agents (GIPA) result in substantially lower ulcer ADR rates compared with non-selective NSAIDs plus GIPA.
    Wolfe, F
    Anderson, J
    Burke, T
    Arguelles, L
    Pettitt, D
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S225 - S225
  • [23] Cyclooxygenase (COX)-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Risk of Hyperkalemia
    Lafrance, Jean-Philippe
    Miller, Donald R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S110 - S111
  • [24] Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors
    Renda, G.
    Zurro, M.
    Santarelli, F.
    Sacchetta, D.
    Tacconelli, S.
    Zimarino, M.
    Patrignani, P.
    Romano, M.
    De Caterina, R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 222 - 222
  • [25] Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review
    Nakata, K.
    Hanai, T.
    Take, Y.
    Osada, T.
    Tsuchiya, T.
    Shima, D.
    Fujimoto, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (10) : 1263 - 1273
  • [26] Morphological features of rat gastric mucosa after acute and chronic treatment with amtolmetin guacyl: Comparison with non-selective and COX-2-selective NSAIDs
    Morini, G
    Guaita, E
    Lazzaretti, M
    Grandi, D
    Coruzzi, G
    DIGESTION, 2003, 68 (2-3) : 124 - 132
  • [27] Effect of Selective and Non-Selective Cyclooxygenase (COX)-1 and COX-2 Inhibitors and Nitric Oxide Releasing Aspirin (No-ASA) On the Chronic Esophagitis in the Rat Model of Barrett's Esophagus
    Majka, Jolanta
    Brzozowski, Tomasz
    Szlachcic, Alexandra
    Pabianczyk, Rafal
    Urbanczyk, Katarzyna
    Tomaszewska, Romana
    Konturek, Stanislaw
    Pawlik, Wieslaw W.
    GASTROENTEROLOGY, 2009, 136 (05) : A597 - A597
  • [28] Effects of selective and non-selective COX-1 and COX-2 inhibitors on chronic gastric ulcer healing
    de La Lastra, CA
    Berenguer, B
    Motilva, V
    La Casa, C
    Herrerias, JM
    Martin, MJ
    GASTROENTEROLOGY, 2001, 120 (05) : A598 - A598
  • [29] Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
    Scheiman, JM
    Yeomans, ND
    Talley, NJ
    Vakil, N
    Chan, FKL
    Tulassay, Z
    Ralnoldi, JL
    Szczepanski, L
    Ung, JA
    Kleczkowski, D
    Ahlbom, H
    Næsdal, J
    Hawkey, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (04): : 701 - 710
  • [30] Short-term administration of non-selective and selective cox-2 nsaids do not interfere with bone repair in rats
    Matsumoto, Mariza Akemi
    De Oliveira, Angelita
    Ribeiro Junior, Paulo Domingos
    Nary Filho, Hugo
    Ribeiro, Daniel Araki
    JOURNAL OF MOLECULAR HISTOLOGY, 2008, 39 (04) : 381 - 387